Stay updated on Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial
Sign up to get notified when there's something new on the Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial page.

Latest updates to the Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page; the error screen otherwise remains unchanged.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check32 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual study record content. This blocks access to core information such as study details, locations, and related materials on this page.SummaryDifference17%

- Check47 days agoChange DetectedPublications section added to the Study Details page includes a citation for the translational population target binding model paper on efgartigimod and notes that publications are automatically filled from PubMed.SummaryDifference0.3%

- Check54 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a backend/maintenance update to the site’s interface.SummaryDifference0.1%

- Check75 days agoChange DetectedThe study record page now displays a server error indicating the content is temporarily unavailable. This replaces the usual study details and navigation with an error message.SummaryDifference15%

Stay in the know with updates to Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial page.